| Antiplatelet and anticoagulant medication usage during stroke rehabilitation: the Post-Stroke Rehabilitation Outcomes Project (PSROP). | |
| | |
MedLine Citation:
|
PMID: 16698733 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Secondary prevention of strokes is an important issue during the admission to the inpatient rehabilitation facility (IRF). There are many clinical practice guidelines with strong levels of evidence that address the secondary prophylaxis of strokes. The Post-Stroke Rehabilitation Outcomes Project (PSROP) database was used to describe the frequency that antiplatelet and/or anticoagulant medications are prescribed for the secondary prophylaxis of a stroke. Of the 1,161 participants in the PSROP, 890 (76.66%) had nonhemorrhagic strokes. Of the participants with nonhemorrhagic strokes, 169 (18.99%) did not receive any antiplatelet or anticoagulant medication. Of 717 participants who did not have an embolic event, 140 (19.5%) did not receive a salicylate, antiplatelet agent, or warfarin. Of 173 participants who had an embolic event, 29 (16.8%) did not receive a salicylate, antiplatelet agent, or warfarin. Unless patients have any medical contraindications to these medications, they should receive these evidence-based treatments for secondary stroke prophylaxis. As more stroke survivors receive antiplatelet and/or anticoagulant medications, it is more likely that the incidence of recurrent strokes will decrease. |
| | |
Authors:
|
Richard D Zorowitz; Randall J Smout; Julie A Gassaway; Susan D Horn |
Related Documents
:
|
12285953 - A model of growth and migration. 10171743 - Medicare program; carrier jurisdiction for claims for durable medical equipment, prosth... 20372913 - General medical interventions in patients with dementia treated in a psychogeriatric unit. |
Publication Detail:
|
Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. |
Journal Detail:
|
Title: Topics in stroke rehabilitation Volume: 12 ISSN: 1074-9357 ISO Abbreviation: Top Stroke Rehabil Publication Date: 2005 |
Date Detail:
|
Created Date: 2006-05-15 Completed Date: 2006-06-22 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 9439750 Medline TA: Top Stroke Rehabil Country: United States |
Other Details:
|
Languages: eng Pagination: 11-9 Citation Subset: IM |
Affiliation:
|
Physical Medicine and Rehabilitation, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Aged, 80 and over Anticoagulants / administration & dosage* Dose-Response Relationship, Drug Drug Administration Schedule Drug Utilization Female Follow-Up Studies Humans Male Middle Aged Outcome Assessment (Health Care) Platelet Aggregation Inhibitors / administration & dosage* Quality of Life Registries Rehabilitation Centers Risk Assessment Severity of Illness Index Stroke / diagnosis, drug therapy*, mortality, rehabilitation* Survival Rate Treatment Outcome United States |
| Chemical | |
Reg. No./Substance:
|
0/Anticoagulants; 0/Platelet Aggregation Inhibitors |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Prophylaxis for and treatment of deep venous thrombosis after stroke: the Post-Stroke Rehabilitation...
Next Document: Antihypertensive medication usage during stroke rehabilitation: the Post-Stroke Rehabilitation Outco...